2012
DOI: 10.2174/1874-470211205020301
|View full text |Cite
|
Sign up to set email alerts
|

The Application of Mass Spectrometry to Proteomics and Metabolomics in Biomarker Discovery and Drug Development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
26
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(26 citation statements)
references
References 0 publications
0
26
0
Order By: Relevance
“…To do this, we plan to use a combined approach of advanced, high-resolution microscopic imaging and metabolomics. Metabolomics should provide an effective way of establishing which biochemical pathways in H. contortus are affected by individual compounds, and will be highly complementary to transcriptomic and proteomic analyses (reviewed by Mikami et al 2012;Vincent and Barrett 2015). Our goal is to study individual phenotypes of various developmental stages of the parasites during treatment with particular drug candidates (different dosages and time points), and quantitatively assess their metabolic profiles compared with untreated controls, which will enable us to verify that chemical knock-down relates specifically to particular pathways or metabolic chokepoints inferred from the druggable genome (cf.…”
Section: Proposed Hit-to-lead Phasementioning
confidence: 99%
“…To do this, we plan to use a combined approach of advanced, high-resolution microscopic imaging and metabolomics. Metabolomics should provide an effective way of establishing which biochemical pathways in H. contortus are affected by individual compounds, and will be highly complementary to transcriptomic and proteomic analyses (reviewed by Mikami et al 2012;Vincent and Barrett 2015). Our goal is to study individual phenotypes of various developmental stages of the parasites during treatment with particular drug candidates (different dosages and time points), and quantitatively assess their metabolic profiles compared with untreated controls, which will enable us to verify that chemical knock-down relates specifically to particular pathways or metabolic chokepoints inferred from the druggable genome (cf.…”
Section: Proposed Hit-to-lead Phasementioning
confidence: 99%
“…Biomarker discovery is a key application in metabolomics that aims to improve disease diagnosis and prognosis while also assessing therapeutic efficacy and toxicity [1][2][3][4]. Metabolomics studies flow sequentially from untargeted to targeted platforms [5][6][7]. Unlike screening in the untargeted approach, targeted quantification of preselected metabolites requires a robust methodology usually with multiple reaction monitoring (MRM) acquisition [6,8,5,7].…”
Section: Introductionmentioning
confidence: 99%
“…Metabolomics studies flow sequentially from untargeted to targeted platforms [5][6][7]. Unlike screening in the untargeted approach, targeted quantification of preselected metabolites requires a robust methodology usually with multiple reaction monitoring (MRM) acquisition [6,8,5,7]. Targeted analysis is typically conducted by coupling tandem mass spectrometry (MS/MS) to gas chromatography (GC) or liquid chromatography (LC) [6,8,5,7].…”
Section: Introductionmentioning
confidence: 99%
“…Pseudotargeted metabolomics method integrates advantages of non-targeted and targeted method, which had good stability, wide linear range, high sensitivity, simple dataset and wide coverage [26,32,33]. MS-based hyphenated techniques [35][36][37] have become powerful tools for metabolomics. LC-MS/MS is highly sensitive and wide coverage of metabolome, which is suitable for the detection of majority metabolites, especially secondary metabolites in plant [38][39][40].…”
Section: Introductionmentioning
confidence: 99%